David F Burgstahler - Net Worth and Insider Trading
David F Burgstahler Net Worth
The estimated net worth of David F Burgstahler is at least $50 Million dollars as of 2024-12-28. David F Burgstahler is the Director of Lantheus Holdings Inc and owns about 300,332 shares of Lantheus Holdings Inc (LNTH) stock worth over $28 Million. David F Burgstahler is the Director, 10% Owner of AngioDynamics Inc and owns about 2,356,996 shares of AngioDynamics Inc (ANGO) stock worth over $21 Million. David F Burgstahler is also the Director, 10% Owner of Syneos Health Inc and owns about 39,713 shares of Syneos Health Inc (SYNH) stock worth over $2 Million. Besides these, David F Burgstahler also holds RVL Pharmaceuticals PLC (RVLPQ) . Details can be seen in David F Burgstahler's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David F Burgstahler has not made any transactions after 2022-08-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David F Burgstahler
David F Burgstahler Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David F Burgstahler owns 8 companies in total, including Organogenesis Holdings Inc (ORGO) , RVL Pharmaceuticals PLC (RVLPQ) , and WideOpenWest Inc (WOW) among others .
Click here to see the complete history of David F Burgstahler’s form 4 insider trades.
Insider Ownership Summary of David F Burgstahler
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ORGO | Organogenesis Holdings Inc | 2018-08-17 | director & 10 percent owner |
RVLPQ | RVL Pharmaceuticals PLC | 2022-08-08 | director & 10 percent owner |
WOW | WideOpenWest Inc | 2017-05-24 | director |
2017-09-07 | director & 10 percent owner | ||
2016-09-19 | director & 10 percent owner | ||
2017-04-12 | director & 10 percent owner | ||
2022-12-01 | director & 10 percent owner | ||
2022-12-01 | director & 10 percent owner |
David F Burgstahler Latest Holdings Summary
David F Burgstahler currently owns a total of 4 stocks. Among these stocks, David F Burgstahler owns 300,332 shares of Lantheus Holdings Inc (LNTH) as of September 7, 2017, with a value of $28 Million and a weighting of 54.91%. David F Burgstahler owns 2,356,996 shares of AngioDynamics Inc (ANGO) as of April 12, 2017, with a value of $21 Million and a weighting of 41.7%. David F Burgstahler also owns 39,713 shares of Syneos Health Inc (SYNH) as of September 19, 2016, with a value of $2 Million and a weighting of 3.39%. The other 1 stocks RVL Pharmaceuticals PLC (RVLPQ) have a combined weighting of 0% among all his current holdings.
Latest Holdings of David F Burgstahler
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
LNTH | Lantheus Holdings Inc | 2017-09-07 | 300,332 | 92.07 | 27,651,567 |
ANGO | AngioDynamics Inc | 2017-04-12 | 2,356,996 | 8.91 | 21,000,834 |
SYNH | Syneos Health Inc | 2016-09-19 | 39,713 | 42.98 | 1,706,865 |
RVLPQ | RVL Pharmaceuticals PLC | 2022-08-08 | 1,032,995 | 0.00 | 103 |
Holding Weightings of David F Burgstahler
David F Burgstahler Form 4 Trading Tracker
According to the SEC Form 4 filings, David F Burgstahler has made a total of 0 transactions in Lantheus Holdings Inc (LNTH) over the past 5 years. The most-recent trade in Lantheus Holdings Inc is the sale of 102,958 shares on September 7, 2017, which brought David F Burgstahler around $2 Million.
According to the SEC Form 4 filings, David F Burgstahler has made a total of 0 transactions in AngioDynamics Inc (ANGO) over the past 5 years. The most-recent trade in AngioDynamics Inc is the sale of 2,350,000 shares on April 12, 2017, which brought David F Burgstahler around $38 Million.
According to the SEC Form 4 filings, David F Burgstahler has made a total of 0 transactions in Syneos Health Inc (SYNH) over the past 5 years. The most-recent trade in Syneos Health Inc is the acquisition of 1,000 shares on September 19, 2016, which cost David F Burgstahler around $43,190.
More details on David F Burgstahler's insider transactions can be found in the Insider Trading History of David F Burgstahler table.Insider Trading History of David F Burgstahler
- 1
David F Burgstahler Trading Performance
GuruFocus tracks the stock performance after each of David F Burgstahler's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David F Burgstahler is -2.89%. GuruFocus also compares David F Burgstahler's trading performance to market benchmark return within the same time period. The performance of stocks bought by David F Burgstahler within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David F Burgstahler's insider trading performs compared to the benchmark.
Performance of David F Burgstahler
David F Burgstahler Ownership Network
David F Burgstahler Owned Company Details
What does Organogenesis Holdings Inc do?
Who are the key executives at Organogenesis Holdings Inc?
David F Burgstahler is the director & 10 percent owner of Organogenesis Holdings Inc. Other key executives at Organogenesis Holdings Inc include director & President and CEO Gary S. Gillheeney , 10 percent owner Albert Erani , and 10 percent owner Michael W Katz .
Organogenesis Holdings Inc (ORGO) Insider Trades Summary
Over the past 18 months, David F Burgstahler made no insider transaction in Organogenesis Holdings Inc (ORGO). Other recent insider transactions involving Organogenesis Holdings Inc (ORGO) include a net sale of 380,000 shares made by Gary S. Gillheeney , and a net sale of 431,786 shares made by Albert Erani .
In summary, during the past 3 months, insiders sold 380,000 shares of Organogenesis Holdings Inc (ORGO) in total and bought 0 shares, with a net sale of 380,000 shares. During the past 18 months, 811,786 shares of Organogenesis Holdings Inc (ORGO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 811,786 shares.
Organogenesis Holdings Inc (ORGO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Organogenesis Holdings Inc Insider Transactions
David F Burgstahler Mailing Address
Above is the net worth, insider trading, and ownership report for David F Burgstahler. You might contact David F Burgstahler via mailing address: C/o Warner Chilcott Holdings Co., Ltd., 100 Enterprise Drive, Rockaway Nj 07866.